Article Text

Download PDFPDF
CASE REPORT
When smear and molecular diagnostics fail: identification of tuberculosis in advanced HIV infection using the newly developed urine lipoarabinomannan lateral-flow assay
  1. Ashar Vijay Dhana1,
  2. Pauline Howell2,
  3. David Spencer1
  1. 1Department of Infectious Diseases, Helen Joseph Academic Hospital, Johannesburg, Gauteng, South Africa
  2. 2Themba Lethu Clinic, Helen Joseph Academic Hospital, Johannesburg, Gauteng, South Africa
  1. Correspondence to Dr Ashar Vijay Dhana, ashdha{at}hotmail.co.za

Summary

In HIV infection, progression of immunodeficiency is associated with increased risk of paucibacillary and disseminated forms of tuberculosis (TB). As a result, the clinical presentation may be atypical and the conventional diagnostic assays often unreliable, resulting in significant treatment delays. Here, we report a case of HIV-associated immune reconstitution inflammatory syndrome and TB meningitis. Although the smear and molecular assays were negative, Mycobacterium tuberculosis was identified in our patient using the new Determine-lipoarabinomannan (LAM) lateral-flow urine ‘dip-stick’ assay. This case report illustrates the clinical value of this assay for the diagnosis of TB in a subgroup of HIV-infected patients with advanced immunodeficiency. Also, although two recent studies have evaluated the use of the Determine TB-LAM assay in clinical settings, to the best of our knowledge, this is the first case report of TB diagnosed using this novel assay.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.